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Elevated concentrations of sphingomyelinase (SMase) have been detected in a variety
of diseases. SMase has been shown to increase muscle derived oxidants and decrease
skeletal muscle force; however, the sub-cellular site of oxidant production has not been
elucidated. Using redox sensitive biosensors targeted to the mitochondria and NADPH
oxidase (Nox2), we demonstrate that SMase increased Nox2-dependent ROS and had no
effect on mitochondrial ROS in isolated FDB fibers. Pharmacological inhibition and genetic
knockdown of Nox2 activity prevented SMase induced ROS production and provided
protection against decreased force production in the diaphragm. In contrast, genetic
overexpression of superoxide dismutase within the mitochondria did not prevent increased
ROS production and offered no protection against decreased diaphragm function in
response to SMase. Our study shows that SMase induced ROS production occurs in
specific sub-cellular regions of skeletal muscle; however, the increased ROS does not
completely account for the decrease in muscle function.
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INTRODUCTION
A variety of chronic diseases such as chronic heart failure
(Doehner et al., 2007; Empinado et al., 2014), inflammatory dis-
ease (Wong et al., 2000), and sepsis (Okazaki et al., 2014) have
been correlated with muscle weakness. Shingomyelinase (SMase),
an enzyme involved in sphingolipid metabolism, has been shown
to be elevated during these conditions (Wong et al., 2000; Claus
et al., 2005; Empinado et al., 2014). Sphingolipids are abundant
in skeletal muscle and their metabolites affect a wide variety
of molecular processes (Nikolova-Karakashian and Reid, 2011).
SMase induced sphingolipid metabolism results in an increase
in ceramide production which has been shown to decrease force
production and increase fatigue and muscle atrophy (Ferreira
et al., 2010, 2012; De et al., 2012; Empinado et al., 2014).
Reactive oxygen species (ROS) have been shown to play a key
role in modulating muscle function (Reid et al., 1993). In con-
tracting skeletal muscle, mitochondria have traditionally been
thought to be the major source of ROS; however, more recent
evidence indicates that NADPH Oxidase (Nox2) may play a pre-
dominant role in ROS generation (Michaelson et al., 2010; Pal
et al., 2013, 2014b; Sakellariou et al., 2013, 2014). In non-muscle
cells, SMase has been shown to increase both mitochondrial
and Nox2-dependent ROS (Sawada et al., 2004; Reinehr et al.,
2005); while in skeletal muscle the mitochondria appear to be the
primary source (Ferreira et al., 2012).
Until recently, there has been no reliable method to determine
the sub-cellular origins of ROS. Traditionally, dichlorofluores-
cein (DCFH), in combination with various antioxidants, has
been used to assess intracellular ROS production and extrapolate
oxidant origin. While DCFH is useful for measuring general
cytosolic ROS production, it is an irreversible dye that cannot
differentiate between subcellular sources of ROS or determine
redox state within the cell. Therefore, redox-sensitive green flu-
orescent probes (roGFP) with an artificial dithiol-disulfide pair
inserted into the GFP (Hanson et al., 2004) were developed to
function as reversible redox sensors and evaluate the local redox
balance within the cell (Dooley et al., 2004; Hanson et al., 2004;
Pal et al., 2013). We have shown that ro-GFPs specifically tar-
geted to Nox2 (p47-roGFP) or the mitochondria (mito-roGFP)
allow for measurement of site-specific ROS production within
skeletal muscle (Michaelson et al., 2010; Pal et al., 2013, 2014a).
Therefore, the aim of this project was to determine the specific
subcellular site of ROS production in response to SMase stimula-
tion. Our data indicate that Nox2 is a major contributor to ROS
production in skeletal muscle (Michaelson et al., 2010; Pal et al.,
2013, 2014b; Sakellariou et al., 2013, 2014); therefore, we hypoth-




C57Bl/6J wild type (WT) and Nox2 knockout (Nox2−/y) were
purchased from Jackson Laboratories (Bar Harbor, ME) and bred
following their breeding strategy. Mitochondrial SOD (MnSOD)
transgenic mice were a kind gift from Dr. Pautler and were geno-
typed by PCR as previously described to verify transgene overex-
pression (Massaad et al., 2009). Redox sensitive GFP probes were
transfected into the flexor digitorum brevis (FDB) of male WT,
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Nox2−/y, and MnSOD mice as previously described (Michaelson
et al., 2010) and in accordance with National Institutes of Health
guidelines and with the approval of the Institutional Animal Care
and Use Committee of Baylor College of Medicine. Briefly, mice
between 8 and 12 weeks of age were anesthetized with isoflurane
(2%) and hyaluronidase (0.5mg/ml) dissolved in sterile saline was
injected subcutaneously into the foot pad of both hindlimb feet.
Two hours later each foot was injected with 20–30µg of rDNA
in PBS; typically the right foot with p47-roGFP and the left foot
with mito-roGFP. Two electrodes were placed subcutaneously at
the proximal and distal FDB tendons to deliver 20 pulses of 150V,
20ms in duration at a frequency of 1Hz with a square pulse stim-
ulator (S48; Grass Technologies, West Warwick, RI). Mice were
returned to their home cage and FDB muscle fibers were isolated
6–8 days later.
ISOLATION OF FDB FIBERS
Mice were deeply anesthetized by isofluorane (2%) inhalation and
euthanized by rapid cervical dislocation. FDB muscles were sur-
gically isolated and incubated at 37◦C in minimal essential media
containing 1% Pen Strep (Life Technologies, Grand Island, NY)
and 0.4% Collagenase A (Roche Applied Science, Indianapolis,
IN) for 2.0 h. FDB muscles were transferred to a serum con-
taining media (10%, Atlanta Biologicals) without collagenase
and triturated gently to release single fibers. Single fibers were
then incubated in 21% O2/5% CO2 at 37◦C until used, typically
12–36 h later.
ROS MEASUREMENTS
Prior to experiments, fibers were plated in 96 well dishes (Greiner
Bio One, Monroe, NC) on ECM gel from Engelbreth-Holm-
Swarm murine sarcoma (Sigma, St. Louis, MO). Intracellular
ROS, in unstimulated FDB fibers, was measured using 6-
carboxy-2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA)
(Invitrogen, Carlsbad, CA) or electroporated site-specific sub-
cellular redox sensitive ROS probes targeted to Nox2 (p47-roGFP)
or the mitochondria (mito-roGFP). All FDB fibers were imaged
at baseline (no drug) and then incubated for 30min at 37◦C with
either vehicle control (0.13% Glycerol final) or SMase (0.5U/ml).
Cells were imaged after 30min, placed back in the incubator for
another 30min and imaged again at 60min. To obtain maxi-
mal oxidation, p47-roGFP and mito-roGFP electroporated fibers
were exposed to 100µM H2O2 for 5min followed by dithiothre-
itol (DTT, 10mM) to obtain maximum reduction. Regions of
interest (ROI) were drawn on the cell and in the background.
Ratio images (403/470) were created by subtracting the mean
background ROI from the mean cell ROI.
DCFH-DA LOADING AND TREATMENT OF SINGLE FDB FIBERS
Plated FDB fibers were washed with 4-(2-Hydroxyethyl)
piperazine-1-ethanesulfonic acid (HEPES) buffered Ringer’s
solution containing (in mM): 146 NaCl, 4.7 KCl, 0.6 MgSO4, 1.8
CaCl, 1.6, NaHCO3, 0.13 NaH2PO4, 7.8 glucose, 20.0 HEPES,
pH 7.3 and incubated with DCFH-DA (5µM) for 30min at
37◦C. The fibers were then washed with Ringer’s solution and
the dye was allowed to de-esterify for 20min at 37◦C prior to
fluorescence microscopy. To prevent light induced oxidation of
DCFH, all cell-loading and imaging was performed in the dark.
In a subset of conditions, prior to DCFH-DA incubation, cells
were incubated with a Nox2 peptide inhibitor, gp-91 ds (5µM;
Biosynthesis Inc., Lewisville, TX), for 45min at 37◦C.
MICROSCOPY
A Sutter Lamda DG-5 Ultra high speed wavelength switcher
was used to excite DCF (480 nm) and ro-GFP (403/12 nm
and 470/20 nm) fluorescence. DCFH-DA and ro-GFP emission
intensity was collected at 510 nm and 535/48 nm, respectively,
on a charge coupled device (CCD) Camera (CoolSNAP MYO,
Photometrics, Tucson, AZ) attached to an Axio Observer (Zeiss)
inverted microscope (40× H2O objective, 1.2 NA) at a rate of
0.1Hz.
EX VIVO FORCE MEASUREMENTS
Diaphragm muscle was surgically dissected from mice and
sectioned into diaphragm strips with one end attached to a
fixed hook and the other to a force transducer (F30, Harvard
Apparatus) using silk suture (4-0) in a physiological saline
solution continuously gassed with 95% O2–5% CO2 at 25◦C.
Diaphragm strips were incubated at 37◦C for 15min and optimal
muscle length (Lo) and voltage (Vmax) were adjusted to elicit max-
imum twitch force. SMase (0.5U/ml) or vehicle control (0.13%
glycerol final) was administered to the muscle bath and force at
300Hz was monitored over time at 0, 30, and 60min with pulse
and train durations of 0.5 and 400ms, respectively. After 60min
of incubation force-frequency characteristics were measured at
stimulation frequencies of 1, 5, 10, 20, 40, 60, 80, 120, 150, 200,
and 300-Hz every minute with pulse and train durations of 0.5
and 250ms. Following a 5min rest period fatigue was assessed
using a matched force protocol in which frequency was adjusted
so force generated by drug treated tissue matched the force of
vehicle control at 40Hz with pulse and train durations of 0.5
and 400ms and a train rate of 0.5Hz. ROS has been suggested to
decrease force by altering Ca2+ sensitivity; therefore a frequency
on the steep part of the force frequency relationship (40Hz) was
chosen to determine if inhibiting SMase induced ROS protected
against decreased muscle force. At the end of the contractile pro-
tocol muscle length was measured using a hand-held electronic
caliper, fiber bundles were removed from the bath and trimmed
of excess bone and connective tissue, blotted dry, and weighed.
Muscle weight and Lo were used to estimate cross-sectional area
and absolute forces expressed as N/cm2 (Close, 1972).
DATA ANALYSIS
Data are reported as mean ± SEM, unless otherwise specified. A
One-Way RM ANOVA was used to measure statistical differences
within a group and a Two-Way RMANOVAwas used for between
group differences. Tukey’s post-hoc test was used when statistical
differences were identified. Statistical analysis was performed in
Origin Pro (OriginLab Corporation, Northhampton, MA) with
significance set a priori at p ≤ 0.05.
RESULTS
EFFECT OF SMase STIMULATION ON GENERAL ROS PRODUCTION
To assess the role of Nox2 in general non-specific intracellular
ROS production, we measured changes in DCF fluorescence in
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FIGURE 1 | SMase increases ROS production through Nox2 in FDB
fibers. SMase increased DCF fluorescence in WT FDB fibers (black bars),
which could be completely inhibited upon pre-incubation with gp91-ds (gray
bars). There was no time-dependent change in the absence of SMase
(white bars). p ≤ 0.05 ∗significantly different from vehicle treated control,
#significantly different from baseline in at least nanimals = 3, ncells = 31.
FDB fibers in the presence or absence of the Nox2 specific pep-
tide inhibitor gp91-ds (Rey et al., 2001; Csanyi et al., 2011; Pal
et al., 2013). SMase resulted in an increase (p ≤ 0.05) in DCF flu-
orescence at 30min and a further increase at 60min, which was
inhibited by pre-incubation with gp91-ds (Figure 1). There was
no change in control fibers over the same time. These data suggest
that in skeletal muscle, SMase stimulates Nox2 dependent ROS
production.
SUBCELLULAR ROS SENSORS TARGETED TO NADPH OXIDASE (Nox2)
AND THE MITOCHONDRIA
While our data indicate a role for Nox2 in SMase induced ROS
production, others have indicated a potential role for mitochon-
drial ROS generation (Sawada et al., 2004; Nikolova-Karakashian
and Reid, 2011; Ferreira et al., 2012). Therefore, we used redox
sensitive GFP probes targeted to Nox2 (p47-roGFP) and themito-
chondria (mito-roGFP) to determine the localization of subcellu-
lar ROS production. Similar to DCFH, in the absence of SMase,
we saw no time dependent effects of ROS production using the
p47-roGFP or mito-roGFP ROS sensors (data not shown). SMase
exposure increased Nox2 derived ROS following 30 and 60min
(Figure 2C), while it had no effect on increasing mitochondrial
oxidant burden (Figure 2D). Representative images demonstrate
the change in fluorescence of both p47-roGFP (Figure 2A) and
mito-roGFP (Figure 2B) in response to SMase. The use of site-
specific redox probes further confirms ROS is produced through
Nox2, with no additional mitochondrial contribution.
GENETIC ABLATION OF Nox2 PREVENTS INCREASED ROS
PRODUCTION
Our data indicate that Nox2 plays a central role in SMase induced
ROS production in skeletal muscle. To further confirm the role
of Nox2 we assessed the effects of SMase stimulated ROS pro-
duction in FDB fibers from Nox2 deficient (Nox2−/y) mice.
SMase induced oxidation of p47-roGFP was completely abolished
(Figure 3A) and, consistent with our previous findings, there was
no change in the oxidation of mito-roGFP (Figure 3B). The lack
of ROS production in Nox2−/y animals further supports the role
of Nox2 as the source of ROS production in adult skeletal muscle
exposed to SMase.
MnSOD OVEREXPRESSION DOES NOT PREVENT SMase INDUCED ROS
PRODUCTION
Previous data have shown increased mitochondrial ROS in
response to SMase stimulation (Ferreira et al., 2012). Genetically
overexpressing mitochondrial superoxide dismutase (MnSOD) in
mice has been shown to reduce contraction induced mitochon-
drial ROS in skeletal muscle (McClung et al., 2010); therefore,
we next wanted to determine if MnSOD overexpression had any
effect on ROS production in response to SMase. A representative
DNA gel image, verifying MnSOD transgene overexpression, is
shown in Figure 4A. In FDBs fromMnSOD overexpressing mice,
SMase induced an increase in Nox2 (p47-roGFP) ROS production
(Figure 4B), while no difference was detected in mitochondrial
ROS production (Figure 4C). These results provide further sup-
port that SMase increases ROS production through Nox2, while
mitochondrial ROS production is not altered.
GENETIC DELETION OF Nox2 PARTIALLY PROTECTS AGAINST SMase
INDUCED FORCE DECREMENT
SMase induced ROS has been shown to decrease force in skeletal
muscle (Ferreira et al., 2010, 2012). Our previous data indicate
decreased ROS production in Nox2−/y animals in response to
SMase; therefore, we wanted to determine whether genetically
inhibiting Nox2-dependent ROS production would provide pro-
tection against SMase induced force depression in diaphragm
strips. In the absence of SMase, there was a non-significant (<4%)
time dependent change in force over 60min (Figures 5A,B).
SMase decreased tetanic force (p ≤ 0.05) in diaphragm strips
from WT, Nox2−/y, and MnSOD overexpressing mice compared
to their respective controls at 30 and 60min (Figures 5A,B). Nox2
deficient animals conferred partial protection against the force
decrement observed in the diaphragm of WT mice at 60min
(Figure 5A), while the MnSOD overexpressing mice offered no
protection in force decrement (Figure 5B). While not statistically
significant (p ≤ 0.08), there was a trend toward protection against
force decrement in the Nox2−/y animals at 30min.
SMase induced force decrements were observed across all
frequencies of stimulation (Figure 6) Genetic deletion of Nox2
protected against SMase induced force loss at all frequencies of
stimulation, with an approximate 51 and 55% protection against
twitch and peak tetanic force loss, respectively (Figure 6A).
Interestingly, diaphragm from Nox2−/y mice displayed enhanced
force production compared to WT animals at higher frequencies
of stimulation (Figure 6A), suggesting that Nox2 specific ROS
regulates muscle function even under basal conditions. Unlike
the protection observed by eliminating Nox2 dependent ROS, no
protection was evident in muscle from MnSOD overexpressing
mice (Figure 6B), confirming our previous data that SMase does
not result in a significant increase in ROS production from the
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FIGURE 2 | SMase increased Nox2 ROS production in WT FDB fibers
with no effect on mitochondrial ROS. (A,B) Representative images of
SMase induced changes in p47-roGFP and mito-roGFP fluorescence,
respectively. (C) Nox2 ROS (p47-roGFP) in FDBs from WT animals was
elevated following SMase at both 30 and 60min. H2O2 and DTT
(100µM and 10mM, black bars) resulted in further oxidation and
reduction of p47-roGFP. (D) Mitochondrial ROS (mito-roGFP) did not
change in response to SMase. H2O2 and DTT (100µM and 10mM,
black bars) resulted in further oxidation and reduction of mito-roGFP.
Fluorescence values were normalized to non-drug treated baseline
measurements. p ≤ 0.05 ∗significantly different from baseline in at least
nanimals = 4, ncells = 11.
FIGURE 3 | Genetic deletion of Nox2 prevents SMase induced
ROS. (A) Nox2 ROS (p47-roGFP) was not altered with SMase in
FDBs from Nox2−/y mice. (B) Mitochondrial ROS (mito-roGFP) did
not change in response to SMase. H2O2 and DTT (100µM and
10mM, black bars) resulted in further oxidation and reduction of
both p47-roGFP and mito-roGFP. Fluorescence values were
normalized to non-drug treated baseline measurements in at least
nanimals = 4, ncells = 12.
mitochondria. Our data indicate that eliminating SMase stim-
ulated Nox2-dependent ROS confers protection against force
decrement and that Nox2-specific ROS may play a role in basal
muscle function.
Nox2 DOES NOT CONFER PROTECTION AGAINST SMase INDUCED
FATIGUE
Oxidants have been shown to promote skeletal muscle fatigue
(Moopanar and Allen, 2005; Bruton et al., 2008) and SMase has
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FIGURE 4 | SMase increased Nox2 ROS production in FDB fibers from
MnSOD overexpressing mice. (A) Representative DNA gel verifying
MnSOD transgene overexpression. (B) SMase increased Nox2 ROS
(p47-roGFP) in muscle from MnSOD overexpressing animals at both 30 and
60min. (C) Mitochondrial ROS (mito-roGFP) did not change in response to
SMase. H2O2 and DTT (100µM and 10mM, black bars) resulted in further
oxidation and reduction of both p47-roGFP and mito-roGFP. Fluorescence
values were normalized to non-drug treated baseline measurements.
p ≤ 0.05 ∗significantly different from baseline in at least nanimals = 3,
ncells = 10.
FIGURE 5 | Genetic deletion of Nox2 protected against diaphragm force
decrement over time. Peak tetanic force was decreased at both 30 and
60min following SMase administration compared with respective controls.
(A) Genetic deletion of Nox2 protected against SMase induced force loss
compared with WT. Black solid = WT control, Black dash = WT SMase, Red
solid = Nox2−/y control, Red dash = Nox2−/y SMase. (B) Overexpressing
MnSOD did not affect force decrement compared to WT. Black solid = WT
control, Black dash = WT SMase, Red solid = MnSOD control, Red dash =
MnSOD SMase. Force values at 30 and 60min were normalized to force
measured in the absence of SMase (baseline). p ≤ 0.05 ∗All genotypes
significantly different from respective control, #Nox2−/y SMase significantly
different from WT SMase in at least nanimals = 6.
been shown to increase fatigue in an oxidant dependent man-
ner (Ferreira et al., 2010). Our results show that Nox2 deficiency
decreases SMase induced oxidant production and offers partial
protection against the decrease in force observed in WT ani-
mals; therefore, we wanted to determine if it also would protect
against SMase induced fatigue. In the vehicle treated control
groups, neither diaphragm from the Nox2−/y nor the MnSOD
overexpressing mice showed altered fatigue compared with WT.
Following SMase administration, there was an increase in the rate
of fatigue for diaphragm from WT, Nox2−/y and MnSOD over-
expressing mice (Figures 7A,B). Neither the Nox2 knockout nor
theMnSOD overexpressingmice conferred any protection against
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FIGURE 6 | Nox2 deletion protected against SMase induced
decreased force. Force was decreased at all frequencies following
SMase administration compared with respective controls. (A) SMase
induced force loss was prevented in diaphragm muscle from Nox2−/y
mice compared to WT at all frequencies. Nox2−/y controls produced
greater force at higher frequencies compared with WT control. Black
solid = WT control, Black dash = WT SMase, Red solid = Nox2−/y
control, Red dash = Nox2−/y SMase. (B) MnSOD overexpression did
not prevent force loss at any frequency compared to WT SMase. Black
solid = WT control, Black dash = WT SMase, Red solid = MnSOD
control, Red dash = MnSOD SMase. P ≤ 0.05 ∗All genotypes
significantly different from respective control, #Nox2−/y SMase
significantly different from WT SMase, ∗∗Nox2 control significantly
different from WT control in at least nanimals = 4.
FIGURE 7 | Genetic ablation of Nox2 or MnSOD overexpression does not
protect against SMase induced fatigue. All genotypes fatigued
approximately 75–80%. SMase induced an increased rate of fatigue in
diaphragm from WT (A,B, black dashed), Nox2−/y (A, red dashed), and
MnSOD (B, red dashed) compared with their respective controls (solid lines).
All force values were normalized to initial force. p ≤ 0.05 ∗All genotypes
significantly different from respective control, †Nox2−/y and MnSOD
significantly different from respective controls in at least nanimals = 6.
increased rate of fatigue (Figures 7A,B). The fatigue index, cal-
culated as the last tetanus divided by the first tetanus, indicated
diaphragm strips from all animals fatigued approximately 75–
80%. These data suggest that fatigue observed in the presence of
SMase is likely independent of ROS.
DISCUSSION
SMase, an enzyme which catalyzes the production of metabolites
that affect a number of cellular functions (Nikolova-Karakashian
and Reid, 2011), has been shown to be elevated in response
to a variety of diseases (Wong et al., 2000; Claus et al., 2005;
Empinado et al., 2014). Increased SMase results in increased
ROS production, which has been thought to negatively impact
muscle force and promote fatigue (Ferreira et al., 2010, 2012).
Previous research has shown that SMase can induce either mito-
chondrial or Nox2 ROS in non-muscle cells (Sawada et al., 2004;
Reinehr et al., 2005) while recent indirect evidence suggests SMase
induced ROS in skeletal muscle was generated by the mitochon-
dria (Ferreira et al., 2012). The majority of ROS production in
skeletal muscle has generally been assumed to be mitochondrial;
however, more recent evidence by our lab and others implicate
Nox2 as a major source of ROS in skeletal muscle (Michaelson
et al., 2010; Pal et al., 2013, 2014b; Sakellariou et al., 2013, 2014).
Using site-specific subcellular redox sensors and various genetic
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animal models, we have shown that SMase induces ROS through
Nox2 and eliminating Nox2-dependent ROS partially recovers
muscle function.
Using the general ROS probe, DCFH, and a Nox2-specific
peptide inhibitor (gp91-ds), we show that Nox2 plays a signif-
icant role in SMase induced ROS production. However, since
DCFH is a non-specific, irreversible probe that does not allow for
the evaluation of cellular redox homeostasis, there is still uncer-
tainty as to the source of ROS within the cell and whether there
is a true shift in the redox balance upon SMase exposure. The
recent development of reversible, site-specific subcellular redox
probes allows for a more thorough evaluation of the source of
ROS production and redox balance in response to various stim-
uli or in response to different disease states. Using ROS sensors
specifically targeted to Nox2 (p47-roGFP) and the mitochondria
(mito-roGFP), we were able to show that SMase increased Nox2
ROS production, but had no effect on mitochondrial ROS in
mouse FDBmuscle. The lack of response of mito-roGFP to SMase
cannot be attributed to the failure of the probe to respond, as the
fluorescence ratio increased approximately two-fold upon oxida-
tion (100µM H2O2). These findings are in disagreement with
other reports, which suggest SMase induces mitochondrial ROS
production in the mouse diaphragm. Using an antioxidant pep-
tide targeted to the inner mitochondrial membrane (SS-31) Reid
and colleagues have suggested that SMase induces ROS genera-
tion from the mitochondria in mouse diaphragm muscle, which
then diffuses into the cytosol where it is detected by the non-
specific ROS probe DCFH (Ferreira et al., 2012). While SS-31
has been shown to localize to the mitochondria Szeto and col-
leagues have also shown that it also localizes to the cytosol (Zhao
et al., 2004). This would allow SS-31 to act as a cytosolic ROS
scavenger; reducing SMase induced ROS production generated
by Nox2. Using pharmacological inhibition of Nox2 (gp91-ds)
and genetic deletion of Nox2 (Nox2−/y), our results confirm that
SMase induces ROS production by activating Nox2 in skeletal
muscle. Furthermore, MnSOD overexpressing mice did not con-
fer protection against SMase induced oxidation of our Nox2 redox
biosensor.
Another potential confounding variable is that mitochondrial
content varies in different muscles based on fiber type compo-
sition. Ferreira et al. (2012) used mouse diaphragm, which is
comprised of 42–49% oxidative (Type I and IIA) fibers with
the mitochondria encompassing approximately 34% of the fiber
volume (Gamboa and Andrade, 2010; Guido et al., 2010; Pal
et al., 2014b). We evaluated ROS production in FDB fibers, which
have been reported to contain approximately 30% oxidative fibers
(Gonzalez et al., 2003) with a mitochondrial volume between 10
and 36% of the fiber volume (Bruton et al., 2003; Laker et al.,
2014). However, if SMase was able to induce a shift in the mito-
chondrial redox balance in muscle with a higher mitochondrial
content (i.e., diaphgram), one would predict that overexpress-
ing MnSOD would protect against SMase induced dysfunction,
which was not observed in our studies. Therefore, we believe that
differences in fiber type or mitochondrial content do not affect
SMase induced mitochondrial ROS production.
ROS has been shown to be a potent modifier of skeletal mus-
cle contractility and fatigue by modulating myofilament calcium
sensitivity (Reid et al., 1993; Andrade et al., 1998; Callahan et al.,
2001; Moopanar and Allen, 2005; Bruton et al., 2008). In the
present study, eliminating SMase induced ROS provided partial
protection against decreased force and had no effect on fatigue.
It is unlikely that reactive nitrogen species, another source of
oxidants in skeletal muscle, could account for the continued
force decrement, as SMase had no effect on NO activity and
blocking NO activity had no effect on SMase induced force
decrement (Ferreira et al., 2010). Sarcoplasmic reticulum (SR)
calcium release has been shown to play an important role in skele-
tal muscle function (Ortenblad et al., 2000; Allen et al., 2008).
The direct metabolite of SMase activity, ceramide, can be fur-
ther metabolized by ceramidase into sphingosine. Sphingosine
has been shown to decrease SR calcium release (Betto et al., 1992;
Sabbadini et al., 1992; McDonough et al., 1994) by decreasing
ryanodine receptor open probability (Needleman et al., 1997;
Sabbadini et al., 1999). Increased levels of sphingosines have also
been shown to decrease myocyte calcium transients, cell short-
ening, and contractile function, (Webster et al., 1994; Oral et al.,
1997; Friedrichs et al., 2002; Favory et al., 2004) in addition to
promoting muscle fatigue (Danieli-Betto et al., 2000). Therefore,
SMase may affect muscle function through a non-ROS depen-
dent mechanism. We are currently investigating the role of these
potential mechanisms in skeletal muscle force depression and
fatigue.
In summary, we have shown that SMase increases Nox2 depen-
dent ROS and has no effect on mitochondrial ROS produc-
tion. Genetically deleting or pharmacologically inhibiting Nox2
reduced SMase stimulated ROS production to control levels. In
addition, Nox2 inhibition provided protection against decreased
force production induced by SMase; however, there was no effect
on muscle fatigue. This indicates that SMase, through its down-
stream metabolites, may affect contractile function in a ROS
independent manner, potentially through modifying SR calcium
release.
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